Join us in our mission to improve the lives of those with lupus nephritis.

The PALIZADE Phase 2b clinical trial is enrolling people living with lupus nephritis.

Zetomipzomib (KZR-616) is an investigational product and has not been approved for commercial use in the United States or any other country for any indication.